104 related articles for article (PubMed ID: 24723343)
1. Biomarker discovery for neuroendocrine cervical cancer.
Lin LH; Chang SJ; Hu RY; Lin MW; Lin ST; Huang SH; Lyu PC; Chou HC; Lai ZY; Chuang YJ; Chan HL
Electrophoresis; 2014 Jul; 35(14):2039-45. PubMed ID: 24723343
[TBL] [Abstract][Full Text] [Related]
2. Proteomic and redox-proteomic study on the role of glutathione reductase in human lung cancer cells.
Fan CY; Chou HC; Lo YW; Wen YF; Tsai YC; Huang H; Chan HL
Electrophoresis; 2013 Dec; 34(24):3305-14. PubMed ID: 24115172
[TBL] [Abstract][Full Text] [Related]
3. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
[TBL] [Abstract][Full Text] [Related]
4. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
5. Proteomics profiling of microdissected low- and high-grade prostate tumors identifies Lamin A as a discriminatory biomarker.
Skvortsov S; Schäfer G; Stasyk T; Fuchsberger C; Bonn GK; Bartsch G; Klocker H; Huber LA
J Proteome Res; 2011 Jan; 10(1):259-68. PubMed ID: 20977276
[TBL] [Abstract][Full Text] [Related]
6. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells.
Lee KH; Yim EK; Kim CJ; Namkoong SE; Um SJ; Park JS
Gynecol Oncol; 2005 Jul; 98(1):45-53. PubMed ID: 15907983
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.
Takikawa M; Akiyama Y; Maruyama K; Suzuki A; Liu F; Tai S; Ohshita C; Kawaguchi Y; Bandou E; Yonemura Y; Yamaguchi K
Oncol Rep; 2006 Oct; 16(4):705-11. PubMed ID: 16969483
[TBL] [Abstract][Full Text] [Related]
10. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
11. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
12. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
13. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
14. Proteomic identification of differentially-expressed proteins in squamous cervical cancer.
Zhu X; Lv J; Yu L; Zhu X; Wu J; Zou S; Jiang S
Gynecol Oncol; 2009 Jan; 112(1):248-56. PubMed ID: 19007971
[TBL] [Abstract][Full Text] [Related]
15. Identification of annexin II as a novel secretory biomarker for breast cancer.
Jeon YR; Kim SY; Lee EJ; Kim YN; Noh DY; Park SY; Moon A
Proteomics; 2013 Nov; 13(21):3145-56. PubMed ID: 24019232
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic protein marker patterns in squamous cervical cancer.
Lomnytska MI; Becker S; Hellman K; Hellström AC; Souchelnytskyi S; Mints M; Hellman U; Andersson S; Auer G
Proteomics Clin Appl; 2010 Jan; 4(1):17-31. PubMed ID: 21137014
[TBL] [Abstract][Full Text] [Related]
17. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
[TBL] [Abstract][Full Text] [Related]
18. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach.
Orenes-Piñero E; Cortón M; González-Peramato P; Algaba F; Casal I; Serrano A; Sánchez-Carbayo M
J Proteome Res; 2007 Nov; 6(11):4440-8. PubMed ID: 17902641
[TBL] [Abstract][Full Text] [Related]
19. Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE).
Hariharan D; Weeks ME; Crnogorac-Jurcevic T
Methods Mol Biol; 2010; 576():197-211. PubMed ID: 19882264
[TBL] [Abstract][Full Text] [Related]
20. Application of 2D-DIGE in cancer proteomics toward personalized medicine.
Kondo T; Hirohashi S
Methods Mol Biol; 2009; 577():135-54. PubMed ID: 19718514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
